Written by:
Lori Lombardo, VP & Therapeutic Area Lead, General Medicine
Adam Callahan, VP & Therapeutic Area Lead, Oncology and Hematology
Breast cancer is the most commonly diagnosed cancer in women globally, with more than 2.3 million new cases each year. While significant progress has been made in diagnosis and treatment, early detection remains one of the most powerful tools for improving patient outcomes.
Breast cancer crosses therapeutic boundaries. It is a central focus in oncology research, yet it also holds critical relevance within the broader scope of women’s health. Whether in cancer-specific protocols or studies targeting hormonal health, autoimmune disorders, or reproductive care, clinical teams must remain attuned to the full spectrum of breast-related symptoms.
Although October is globally recognized as Breast Cancer Awareness Month, the need for clinical awareness extends far beyond this period. For those working in research and care delivery, consistent vigilance is an ongoing responsibility.
Looking Beyond the Lump: 12 Breast Cancer Symptoms
A hard lump is often seen as the hallmark of breast cancer, but it is only one of many possible signs. Some of the most serious cases present with symptoms that are subtle or misattributed to benign causes.
The Know Your Lemons Foundation outlines 12 potential symptoms that clinicians and study teams should recognize and educate participants about:
- Hard lump – Firm, often immobile mass within breast tissue.
- Thick area – A denser region that feels different from surrounding tissue.
- Dimple – Skin indentation or puckering, often from an underlying tumor.
- Nipple crust – Persistent flaking or scaling around the nipple.
- Redness or heat – Unexplained localized inflammation.
- New fluid – Clear, bloody, or spontaneous nipple discharge.
- Skin sores – Non-healing lesions or ulceration on the breast surface.
- Bump – A visible or palpable protrusion or localized swelling.
- Growing vein – Prominent or newly visible veins.
- Sunken nipple – Sudden nipple inversion or flattening.
- New shape or size – Unexplained asymmetry or contour change.
- “Orange peel” skin – Pitting or thickening of the skin, often a sign of lymphatic involvement.
These symptoms can present alone or in combination and may be easy to overlook. For researchers and healthcare professionals working across both oncology and women’s health, maintaining awareness of these signs is essential.
Implications for Clinical Research
Incorporating breast cancer vigilance into trial design and execution is not limited to oncology protocols. Many studies, particularly those involving hormonal therapies, reproductive health, or immunomodulators, may involve populations at elevated or undiagnosed risk.
Key practices include:
- Baseline documentation – Capture pre-existing breast symptoms or findings at screening to serve as reference for future assessments.
- Participant education – Equip participants with plain-language materials on what changes to look for and report.
- Active monitoring – Use targeted symptom checks and encourage open reporting throughout the study lifecycle.
- Staff training – Ensure research staff can recognize both typical and atypical breast cancer presentations and know how to escalate appropriately.
Conclusion
Breast cancer touches multiple areas of clinical research. Its symptoms are not always obvious, and its impact is not confined to oncology alone. As professionals working in both oncology and women’s health, we share the responsibility of early recognition, within and beyond our protocols.
By broadening awareness, reinforcing education, and integrating proactive monitoring into trials, we help safeguard participant well-being and contribute to earlier intervention and improved outcomes.